Home > Insider Trading > Filing (0000921895-24-000337)

Filing Details

Accession Number:: 0000921895-24-000337
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-09 20:40:05
Reporting Period:: 2024-02-08

Accepted Time:: 2024-02-09 20:40:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1788028	Jasper Therapeutics Inc.	JSPR	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1114916	Balaji Venkataraman	100 North Main Street Suite 301 Alpharetta GA 30009	No	No	Yes	No
1822834	Avego Healthcare Capital, L.p.	100 North Main Street Suite 301 Alpharetta GA 30009	No	No	No	Yes
1848809	Velan Capital Investment Management Lp	100 North Main Street Suite 301 Alpharetta GA 30009	No	No	Yes	No
1886177	Avego Management Llc	100 North Main Street Suite 301 Alpharetta GA 30009	No	No	No	Yes
1964335	Adam Morgan	100 North Main Street Suite 301 Alpharetta GA 30009	No	No	Yes	No
1964353	Velan Capital Holdings Llc	100 North Main Street Suite 301 Alpharetta GA 30009	No	No	No	Yes
1964355	Velan Capital Management Llc	100 North Main Street Suite 301 Alpharetta GA 30009	No	No	Yes	No
1964356	Velan Capital Master Fund Lp	89 Nexus Way Grand Cayman E9 KY1-9009	No	No	No	Yes
1964446	Avego Healthcare Capital Holdings, Llc	100 North Main Street Suite 301 Alpharetta GA 30009	No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2024-02-08	350,000	$12.95	1,188,500	No	4	P	Indirect	By Velan Capital Master Fund LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Velan Capital Master Fund LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	245,328	Indirect	By Avego Healthcare Capital, L.P.

Footnotes

This Form 4 is filed jointly by Velan Capital Master Fund LP ("Velan Master"), Avego Healthcare Capital, L.P. ("Avego Fund"), Velan Capital Holdings LLC ("Velan GP"), Avego Healthcare Capital Holdings, LLC ("Avego GP"), Avego Management, LLC ("Avego Management"), Velan Capital Investment Management LP ("Velan Capital"), Velan Capital Management LLC ("Velan IM GP"), Balaji Venkataraman and Adam Morgan (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that no longer collectively beneficially owns more than 10% of the Issuer's outstanding shares. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Securities owned directly by Velan Master. As the general partner of Velan Master, Velan GP may be deemed to beneficially own the securities owned directly by Velan Master. As the investment manager of Velan Master, Velan Capital may be deemed to beneficially own the securities owned directly by Velan Master. As the general partner of Velan Capital, Velan IM GP may be deemed to beneficially own the securities owned directly by Velan Master. As the managing members of Velan GP and Velan IM GP, Messrs. Venkataraman and Morgan may be deemed to beneficially own the securities owned directly by Velan Master.
Securities owned directly by Avego Fund. As the general partner of Avego Fund, Avego GP may be deemed to beneficially own the securities owned directly by Avego Fund. As the co-investment manager of Avego Fund, Avego Management may be deemed to beneficially own the securities owned directly by Avego Fund. As the co-investment manager of Avego Fund, Velan Capital may be deemed to beneficially own the securities owned directly by Avego Fund. As the general partner of Velan Capital, Velan IM GP may be deemed to beneficially own the securities owned directly by Avego Fund. As the managing member of each of Avego GP, Avego Management, Velan GP and Velan IM GP, Mr. Venkataraman may be deemed to beneficially own the securities owned directly by Avego Fund. As the managing member of each of Velan GP and Velan IM GP, Mr. Morgan may be deemed to beneficially own the securities owned directly by Avego Fund.
Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected on January 4, 2024.